MEX3A determines in vivo hepatocellular carcinoma progression and induces resistance to sorafenib in a Hippo-dependent way.
Fang S, Zheng L, Chen X, Guo X, Ding Y, Ma J, Ding J, Chen W, Yang Y, Chen M, et al. Hepatol Int. 2023 Dec; 17(6):1500-1518. Epub 2023 Jul 17.